3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
558
Leukemia
281
Precursor Cell Lymphoblastic Leukemia-Lymphoma
231
Lymphoma
159
Myelodysplastic Syndromes
110
Burkitt Lymphoma
90
Congenital Abnormalities
85
Lymphoma, Non-Hodgkin
84
Leukemia, Monocytic, Acute
83
Leukemia, Myelomonocytic, Acute
81
Lymphoma, Large B-Cell, Diffuse
79
Leukemia, Erythroblastic, Acute
74
Leukemia, Megakaryoblastic, Acute
71
Recurrence
69
Lymphoma, Mantle-Cell
69
Lymphoma, Follicular
48
Leukemia, Myelomonocytic, Chronic
43
Leukemia, Biphenotypic, Acute
43
Hodgkin Disease
43
Lymphoma, Large-Cell, Immunoblastic
36
Blast Crisis
36
Anemia, Refractory, with Excess of Blasts
36
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
35
Leukemia, Lymphocytic, Chronic, B-Cell
32
Myeloproliferative Disorders
30
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
27
Lymphoma, B-Cell, Marginal Zone
23
Leukemia, Myeloid, Chronic-Phase
23
Leukemia, Eosinophilic, Acute
23
Leukemia, Basophilic, Acute
22
Interventions
Doxorubicin
15
Exercise
9
Cyclophosphamide
9
Dexrazoxane
8
Razoxane
6
Carvedilol
6
Vincristine
4
Trastuzumab
4
Radiotherapy
4
Filgrastim
4
Docetaxel
4
Methotrexate
3
Granulocyte Colony-Stimulating Factor
3
Etoposide
3
Echocardiography
3
Atorvastatin
3
salicylhydroxamic acid
2
sacubitril and valsartan sodium hydrate drug combination
2
empagliflozin
2
dapagliflozin
2
Tablets
2
Silymarin
2
Prednisone
2
Paclitaxel
2
Neoadjuvant Therapy
2
Leucovorin
2
Ivabradine
2
High-Intensity Interval Training
2
Epirubicin
2
Electrocardiography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Cardiotoxicity
×
Cytarabine
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled